Pharmacokinetics of (-)-β-D-2-aminopurine dioxolane and (-)-β-D-2- amino-6-chloropurine dioxolane and their antiviral metabolite (-)-β-D- dioxolane guanine in rhesus monkeys

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2332-2336

  Chen, Huachun ^a   Boudinot, F Douglas ^a   Chu, Chung K ^a   Mcclure, Harold M ^b   Schinazi, Raymond F ^b,c,d  

^a UNIVERSITY OF GEORGIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DRUG METABOLITE; NUCLEOSIDE DERIVATIVE; PRODRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHESUS MONKEY;

EID: 0029824186     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2332     Document Type: Article

References (13)

1. Burger, D. M., C. L. Kraaijeveld, P. L. Meenhorst, J. W. Mulder, C. H. W. Koks, A. Bult, and J. H. Beijnen. 1993. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV. AIDS 7:1581-1587.
2. Chen, H., K. K. Manouilov, C. K. Chu, R. F. Schinazi, H. M. McClure, and F. D. Boudinot. High-performance liquid chromatographic determination of (-)-β-D-2-aminopurine dioxolane and (-)-β-D-2-amino-6-chloropurine dioxolane and their metabolite (-)-β-D-dioxolane guanine. Submitted for publication.
3. Collins, J. M., R. W. Klecker, J. A. Kelly, J. S. Roth, C. L. McCully, F. M. Balls, and D. G. Poplack. 1988. Pyrimidine dideoxyribonucleoside: selectivity of penetration into cerebrospinal fluid. J. Pharmacol. Exp. Ther. 245:466-470.
4. Ho, D. D., T. R. Rota, R. T. Schooley, J. C. Kaplain, J. D. Allan, J. E. Groopman, L. Resnick, D. Felsenstein, C. A. Andrews, and M. S. Hirsch. 1985. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 313:1493-1497.
5. Kim, H. O., R. F. Schinazi, S. Nampalli, K. Shanmuganathan, D. L. Cannon, A. J. Alves, L. S. Jeong, J. W. Beach, and C. K. Chu. 1993. 1,3-Dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes. J. Med. Chem. 36:30-37.
6. Metzler, D. M., G. L. Elfring, and A. J. McEwen. 1974. NONLIN, a computer program for nonlinear least-squares regression. Biometrics 30:552-563.
7. National Institutes of Health. 1985. Guide for the care and use of laboratory animals. National Institutes of Health, Bethesda, Md.
8. Rajagopalan, P., F. D. Boudinot, C. K. Chu, H. M. McClure, and R. F. Schinazi. 1994. Pharmacokinetics of (-)-β-D-2,6-diaminopurine dioxolane and its metabolite dioxolane guanosine in rhesus monkeys. Pharm. Res. 11(Suppl.):381.
9. Rajagopalan, P., F. D. Boudinot, C. K. Chu, B. C. Tennant, B. H. Baldwin, and R. F. Schinazi. 1996. Pharmacokinetics of (-)-β-D-2,6-diaminopurine dioxolane and its metabolite, dioxolane guanosine, in woodchucks (Marmota monax). Antivir. Chem. Chemother. 7:65-70.
10. Rocci, M. L., and W. J. Jusko. 1983. LAGRAN program for area and moments in pharmacokinetic analysis. Comput. Programs Biomed. 16:203-216.
11. Schinazi, R. F., and C. K. Chu. Unpublished results.
12. Schinazi, R. F., H. M. McClure, F. D. Boudinot, Y. Jxiang, and C. K. Chu. 1994. Development of (-)-β-D-2,6-diaminopurine dioxolane as a potential antiviral agent. Antivir. Res. 23(Suppl.):81.
13. Voet, D., and J. G. Voet. 1990. Biochemistry, p. 758-762. John Wiley & Sons, Inc., New York.